CStone Pharmaceuticals (CStone Pharmaceuticals) Ending Cash Position : $0.00 Mil (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is CStone Pharmaceuticals Ending Cash Position?

CStone Pharmaceuticals's Ending Cash Position for the quarter that ended in Jun. 2023 was $0.00 Mil.

CStone Pharmaceuticals's quarterly Ending Cash Position declined from Jun. 2022 ($109.25 Mil) to Dec. 2022 ($80.14 Mil) and declined from Dec. 2022 ($80.14 Mil) to Jun. 2023 ($0.00 Mil).

CStone Pharmaceuticals's annual Ending Cash Position declined from Dec. 2021 ($116.61 Mil) to Dec. 2022 ($80.14 Mil) but then increased from Dec. 2022 ($80.14 Mil) to Dec. 2023 ($139.59 Mil).

CStone Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for CStone Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Ending Cash Position Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

160.61

462.52

116.61

80.14

139.59

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial									116.61	109.25	80.14	-	-

CStone Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

CStone Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	78.245	+	61.341
	=	139.59

CStone Pharmaceuticals's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.00

CStone Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (CStone Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (OTCPK:CSPHF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

02616:Hong Kong PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.